SEC Form 4 · accession 0001610717-26-000290
Revolution Medicines, Inc. · RVMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lorence H. Kim
Director
Period of report
Jun 18, 2026
Accepted (ET)
Jun 23, 2026 · 5:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001628171
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 18, 2026 | A | 1,191 | $0.00 | A | 74,281 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $162.99 | Jun 18, 2026 | A | 3,127 | A | — | Jun 18, 2036 | Common Stock | 3,127 | 3,127 | D |
Explanation of responses
- F1Includes 1,191 restricted stock units.
- F2Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.